Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Enlight - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Enlight

Approved

STANDARD

Enlight

Whan In Pharm. Co., Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: b8cab4f278f1ba21
Company: Whan In Pharm. Co., Ltd.
Type: Standard

Approval Details

Approval Id: b8cab4f278f1ba21
Drug Approval Philippines Name: Enlight
Product Name: Enlight
Registration Number: DRP-16487
Brand Name: Enlight
Generic Name: Aripiprazole
Dosage Form: Tablet
Dosage Strength: 10 mg
Manufacturer: Whan In Pharm. Co., Ltd.
Importer: JLT Pharma, Inc.
Distributor: JLT Pharma, Inc.
Issuance Date: 26 March 2025
Expiry Date: 26 March 2030
Pharmacologic Category: Antipsychotic
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

b8cab4f278f1ba21

Type

Standard

Back to Philippines FDA Approvals